Prabhavathi Fernandes - 28 Jun 2024 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jul 2024, 16:09:27 UTC
Prior SEC filing
09 Jun 2023
Next SEC filing
02 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Prabhavathi Fernandes by Shankar Musunuri, her attorney-in-fact

Key filing fact

Prabhavathi Fernandes filed Form 4 for Ocugen, Inc. (OCGN) on 02 Jul 2024.

Key facts

  • This page summarizes Prabhavathi Fernandes's Form 4 filing for Ocugen, Inc. (OCGN).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 02 Jul 2024, 16:09.

Change

  • Previous filing in this sequence was filed on 09 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OCGN transaction Derivative

Option (Right to Buy)

Award

Transaction value
$0
Shares
+66,929
Change %
Price
$0.000000
Shares after
66,929
Date
28 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
66,929
Exercise price
$1.55
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option vests upon the earlier of (a) June 28, 2025 or (b) Ocugen, Inc.'s next annual meeting of stockholders, subject to the Reporting Person's continued service through the applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .